LENVATINIB

Overview

LENVATINIB is a Schedule H drug.
Lenvatinib is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Lenvatinib is used to treat thyroid cancer.Lenvatinib is also used together with everolimus (Afinitor) to treat advanced kidney cancer.

Usage

LENVATINIB is generally used to treat: Thyroid Cancer, Kidney Cancer

Frequently Asked Questions

Q: Is it safe on my liver?
A: Check with your Doctor first

Q: Is it safe on my kidney?
A: Check with your Doctor first

Q: Can I take it with alcohol?
A: Not Safe

Q: Is it safe for children?
A: Not Advised for age < 18yrs

Q: Is it safe to take for someone breastfeeding?
A: Check with your Doctor first

How Do I Take It?

Route of Administration: Oral

Precautions

Do not take the drug if you are planning to become pregnant as the drug is capable of decreasing the fertility in men and women. Blood pressure should be monitored regularly while taking the drug as it can cause hypertension. Discontinue the drug if there is liver failure or nephrotic syndrome. Do not use the drug if there is any gastrointestinal perforation or life threatening fistula. Discontinue the drug if there is any signs of neurologic symptoms which may indicate reversible posterior leukoencephalopathy syndrome (RPLS). RPLS is characterized by symptoms of headache, seizures, confusion and loss of vision. Do not use the drug if there is any bleeding problem or heart problems like irregular heartbeats and heart failure.

Symptoms of Overdosage

LENVATINIB over-dosage can result in: Difficulty Breathing

Common Side-Effects

LENVATINIB : Dry Mouth, Hoarse Voice, Fatigue (tiredness), Head Headache, Difficulty Sleeping, Loose Motion, Constipation, Abdomen Upset Stomach, Nausea, Vomit, Dizziness, Lightheadedness

Disease Interactions

LENVATINIB can interfere with: Purpura, Thrombotic Thrombocytopenic, Pulmonary Edema, Diarrhoea, Gastrointestinal Bleeding, Hypertension, Hypocalcemia, Hypothyroidism, Proteinuria, Heart Arrhythmias, Acute Renal Failure

Technical Classification

LENVATINIB is categorized as:
  • MULTIKINASE INHIBITORS / ANTINEOPLASTICS
  • VEGF/VEGFR INHIBITORS / ANTINEOPLASTICS

Storage Conditions

Room Temperature (Between 15 To 25 C)

Available Alternatives

What are the other drugs with similar Ingredients?

LENVATINIBLENVATINIB